Science and Technology
Source: (remove) : Toronto Star
RSSJSONXMLCSV
Science and Technology
Source: (remove) : Toronto Star
RSSJSONXMLCSV
Tue, May 13, 2025

Microbix & Aurevia Introduce Novel EQA Scheme


//science-technology.news-articles.net/content/2 .. microbix-aurevia-introduce-novel-eqa-scheme.html
Published in Science and Technology on Tuesday, May 13th 2025 at 7:42 GMT by   Print publication without navigation

  • MISSISSAUGA, Ontario and HELSINKI, Finland, May 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix
  • ), a life sciences innovator, manufacturer, and exporter, and Aurevia Oy via

Microbix Biosystems Inc. and Aurelia Bioscience Ltd. have launched a novel External Quality Assessment (EQA) scheme for point-of-care (POC) infectious disease tests, specifically targeting the growing market for rapid diagnostic tests (RDTs). This new EQA program, named REDx® QAP, is designed to enhance the quality assurance of POC tests for infectious diseases such as HIV, malaria, and syphilis, which are crucial for global health initiatives. The scheme utilizes Microbix's QAPs™ (Quality Assessment Products) and Aurelia's REDx® platform to provide a comprehensive quality control solution that can be used in resource-limited settings. The collaboration aims to improve the reliability and accuracy of POC testing, thereby supporting better patient outcomes and public health management worldwide.

Read the Full Toronto Star Article at:
[ https://www.thestar.com/globenewswire/microbix-aurevia-introduce-novel-eqa-scheme/article_499b73d0-1026-59a5-b8c1-62f7601a5345.html ]